Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

NCT05702463 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT05702463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05702463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
Lead sponsor
Montreal Heart Institute
Phase
Phase 1
Overall status
Recruiting
Start date
June 13, 2023
Completion date
July 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, diabetes mellitus, type 2, platelet aggregation, platelet aggregation inhibitors, type 2 diabetes